(Q35565342)

English

Insulin glargine reduces carotid intimal hyperplasia after balloon catheter injury in Zucker fatty rats possibly by reduction in oxidative stress

scientific article published on 10 April 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Insulin glargine reduces carotid intimal hyperplasia after balloon catheter injury in Zucker fatty rats possibly by reduction in oxidative stress (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

catheterization

0 references

insulin glargine

1 reference

based on heuristic

inferred from title

Sergiy Sukhanov

object named as

Sergiy Sukhanov

2

0 references

Patrice Delafontaine

object named as

Patrice Delafontaine

6

0 references

Philip J. Kadowitz

7

object named as

Philip J Kadowitz

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Subramanyam N Murthy

1

object named as

Subramanyam N Murthy

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

author name string

Jennifer McGee

3

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Joel A Greco

4

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Surabhi Chandra

5

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Dennis B McNamara

8

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Vivian A Fonseca

9

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

publication date

10 April 2009

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Molecular and Cellular Biochemistry

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

330

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

1-8

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Animal models of catheter-induced intimal hyperplasia in type 1 and type 2 diabetes and the effects of pharmacologic intervention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

12 July 2018

Pharmacokinetic and pharmacodynamic advantages of insulin analogues and premixed insulin analogues over human insulins: impact on efficacy and safety

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

12 July 2018

Cardiometabolic risk: a Framingham perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

12 July 2018

Postprandial dysmetabolism: the missing link between diabetes and cardiovascular events?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

12 July 2018

Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

12 July 2018

The role of recombinant insulin-like growth factor I in the treatment of the short child

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

12 July 2018

Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

12 July 2018

Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

12 July 2018

Recombinant human insulin-like growth factor I (rhIGF-I) and rhIGF-I/rhIGF-binding-protein-3: new growth treatment options?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

12 July 2018

Postprandial hyperglycemia and cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

12 July 2018

Dispelling myths and removing barriers about insulin in type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

12 July 2018

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

12 July 2018

Beneficial effects of insulin on endothelial function, inflammation, and atherogenesis and their implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

12 July 2018

Role of insulin secretagogues and insulin sensitizing agents in the prevention of cardiovascular disease in patients who have diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

12 July 2018

Insulin and insulin resistance: impact on blood pressure and cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

12 July 2018

Pre-diabetes, insulin resistance, inflammation and CVD risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

12 July 2018

Endothelial dysfunction in human diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

12 July 2018

Effect of insulin therapy on endothelium-dependent dilation in type 2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

12 July 2018

Specificity in ligand binding and intracellular signalling by insulin and insulin-like growth factor receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

12 July 2018

Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

12 July 2018

Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

12 July 2018

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

12 July 2018

Evidence that upregulation of serum IGF-1 concentration can trigger acceleration of diabetic retinopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

12 July 2018

Cardiological aspects of growth hormone and insulin-like growth factor-I.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

12 July 2018

Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

12 July 2018

Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

12 July 2018

Effects of high doses of insulin on systemic haemodynamics and regional blood flows in dogs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

12 July 2018

Pituitary factors in blood plasma are necessary for smooth muscle cell proliferation in response to injury in vivo.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

12 July 2018

Insulin therapy improves endothelial function in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-009-0094-5

21 January 2018

Effects of balloon injury on neointimal hyperplasia in streptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-009-0094-5

21 January 2018

Development of insulin resistance and hyperphagia in Zucker fatty rats

1 reference

https://api.crossref.org/works/10.1007%2FS11010-009-0094-5

21 January 2018

Insulin resistance in patients with stroke is related to visceral fat obesity and adipocytokines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

26 September 2018

Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

26 September 2018

IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

26 September 2018

IGF-1 receptor signalling determines the mitogenic potency of insulin analogues in human smooth muscle cells and fibroblasts.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

26 September 2018

Recombinant human insulin-like growth factor-I treatment inhibits gluconeogenesis in a transgenic mouse model of type 2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

26 September 2018

Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

26 September 2018

Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

26 September 2018

Differential effects of peroxisome proliferator activator receptor-alpha and gamma ligands on intimal hyperplasia after balloon catheter-induced vascular injury in Zucker rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

26 September 2018

3.5 years of insulin therapy with insulin glargine improves in vivo endothelial function in type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

26 September 2018

Glargine and regular human insulin similarly acutely enhance endothelium-dependent vasodilatation in normal subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

26 September 2018

Oral insulin supplementation attenuates atherosclerosis progression in apolipoprotein E-deficient mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

26 September 2018

Insulin therapy improves insulin-stimulated endothelial function in patients with type 2 diabetes and ischemic heart disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

26 September 2018

Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

26 September 2018

Recombinant human insulin-like growth factor I treatment for 1 week improves metabolic control in type 2 diabetes by ameliorating hepatic and muscle insulin resistance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

26 September 2018

IGF-I increases forearm blood flow without increasing forearm glucose uptake.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3221412

26 September 2018

Increased abundance of insulin/insulin-like growth factor-I hybrid receptors in skeletal muscle of obese subjects is correlated with in vivo insulin sensitivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/19360379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort

1 reference

https://pubmed.ncbi.nlm.nih.gov/19360379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin stimulates arterial neointima formation in normal rats after balloon injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/19360379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with insulin glargine does not suppress serum IGF-1

1 reference

https://pubmed.ncbi.nlm.nih.gov/19360379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular events and insulin therapy: a retrospective cohort analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19360379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Similar cardiovascular effects of growth hormone and insulin-like growth factor-I in rats after experimental myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/19360379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the reproductive toxicity and embryotoxicity of insulin glargine (LANTUS) in rats and rabbits

1 reference

https://pubmed.ncbi.nlm.nih.gov/19360379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of insulin receptor substrate-2 causes progressive neointima formation in response to vessel injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/19360379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11010-009-0094-5

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35565342&oldid=2197486730"